Chronic Hepatitis C virus infection in Swiss primary care practices: Low case loads-high barriers to treatment?

被引:4
作者
Overbeck, Kathrin [2 ]
Bruggmann, Philip [3 ]
Helbling, Beat [1 ]
机构
[1] Stadtspital Waid, Dept Gastroenterol & Hepatol, CH-8037 Zurich, Switzerland
[2] Univ Zurich Hosp, Dept Internal Med, Zurich, Switzerland
[3] ARUD Assoc Risk Reduct Drugs, Zurich, Switzerland
关键词
Hepatitis C; primary care physician; disease workup; patient monitoring; barriers to treatment; THERAPY; MANAGEMENT; PREDICTORS; PHYSICIANS; PATIENT; RATES;
D O I
10.3109/13814788.2010.545122
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Background: The primary care physician (PCP) diagnoses chronic Hepatitis C virus (HCV) infection in most patients. He serves as gatekeeper and plays a key role in counselling and treatment guidance. Objectives: To calculate the approximate HCV caseload per practice and characterize PCPs management of the disease; in particular, to determine antiviral treatment rates and reasons for PCPs for withholding treatment. The ultimate objective was to identify potentially modifiable barriers to treatment. Methods: A confidential self-administered questionnaire centred on the above-mentioned questions was distributed to 2371 Swiss primary care physicians. All respondents of the main questionnaire received an additional small questionnaire focussed on the initial disease workup. Descriptive statistics were used to describe questionnaire responses and PCP demographics. Results : The response rate was 53.1%. Of all participating PCPs (n = 1084), 86.2% reported having patients with chronic HCV, with an average number of 4 patients per practice; 18.6% (n = 142) of PCPs did not monitor their chronic HCV patients. Two-thirds (66.8%) of the sample chronic HCV patient population (n = 4626) never received antiviral therapy. The main reasons given by PCPs for withholding treatment were HCV-specialist advice, patient preference, normal liver enzymes and patient related factors like substance abuse or psychiatric co morbidity. Conclusions: Most PCPs follow patients with chronic hepatitis C, but practice caseloads are low, which may account for insecurity in managing this complex disease.
引用
收藏
页码:103 / 108
页数:6
相关论文
共 50 条
  • [41] Assessment of motivating factors associated with the initiation and completion of treatment for chronic hepatitis C virus (HCV) infection
    Fusfeld, Lauren
    Aggarwal, Jyoti
    Dougher, Carly
    Vera-Llonch, Montserrat
    Bubb, Stephen
    Donepudi, Mrudula
    Goss, Thomas F.
    BMC INFECTIOUS DISEASES, 2013, 13
  • [42] Access to care of patients with chronic hepatitis C virus infection in a university hospital: Is opioid dependence a limiting condition?
    Perut, Valerie
    Labalette, Celine
    Sogni, Philippe
    Ferrand, Isabelle
    Salmon-Ceron, Dominique
    Vidal-Trecan, Gwenaelle
    DRUG AND ALCOHOL DEPENDENCE, 2009, 104 (1-2) : 78 - 83
  • [43] Treatment and primary prevention in people who inject drugs for chronic hepatitis C infection: is elimination possible in a high-prevalence setting?
    Gountas, Ilias
    Sypsa, Vana
    Anagnostou, Olga
    Martin, Natasha
    Vickerman, Peter
    Kafetzopoulos, Evangelos
    Hatzakis, Angelos
    ADDICTION, 2017, 112 (07) : 1290 - 1299
  • [44] Treatment of Hepatitis C Virus Infection in Kidney Transplant Recipients: Case Report
    Caeiro, F.
    Baptista, V.
    Rodrigues, N.
    Carvalho, D.
    Aires, I.
    Remedio, F.
    Nolasco, F.
    TRANSPLANTATION PROCEEDINGS, 2011, 43 (01) : 259 - 262
  • [45] Relevance of low viral load in haemodialysed patients with chronic hepatitis C virus infection
    Sperl, Jan
    Frankova, Sona
    Senkerikova, Renata
    Neroldova, Magdalena
    Hejda, Vaclav
    Volfova, Miroslava
    Merta, Dusan
    Viklicky, Ondrej
    Spicak, Julius
    Jirsa, Milan
    WORLD JOURNAL OF GASTROENTEROLOGY, 2015, 21 (18) : 5496 - 5504
  • [46] Cirrhosis related to Chronic Hepatitis C Virus Infection and Factors Associated in Treatment-naive Hepatitis C Patients
    Darnindro, Nikko
    Mulyana, Edi
    Harahap, Arnold
    Manurung, Annela
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2018, 33 : 136 - 136
  • [47] Prevalence of cryoglobulinemia in chronic hepatitis C virus infection and response to treatment with interferon-α
    Akriviadis, EA
    Xanthakis, I
    Navrozidou, C
    Papadopoulos, A
    JOURNAL OF CLINICAL GASTROENTEROLOGY, 1997, 25 (04) : 612 - 618
  • [48] Ribavirin treatment in dialysis patients with chronic hepatitis C virus infection -: a pilot study
    Bruchfeld, A
    Ståhle, L
    Andersson, J
    Schvarcz, R
    JOURNAL OF VIRAL HEPATITIS, 2001, 8 (04) : 287 - 292
  • [49] A case of multiple extrahepatic manifestations in a patient with untreated, chronic hepatitis C virus infection
    Meillier, Andrew
    McGee, Jean
    Kartan, Saritha
    Baskin, Stuart
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2014, 19 : 93 - 94
  • [50] Chronic Pain Treatment and Health Service Utilization of Veterans with Hepatitis C Virus Infection
    Lovejoy, Travis I.
    Dobscha, Steven K.
    Cavanagh, Renee
    Turk, Dennis C.
    Morasco, Benjamin J.
    PAIN MEDICINE, 2012, 13 (11) : 1407 - 1416